<div id="readability-page-1">05:35 AM EST, 01/12/2026 (MT Newswires) -- RxSight ( RXST ) , an ophthalmic medical device company, said Sunday it has appointed Mark Wilterding as chief financial officer, starting January 11.Wilterding, who has more than 25 years of financial leadership experience, most recently served as senior vice president of global finance at Edwards Lifesciences. He previously worked at Medtronic and began his career in banking at Citi and Credit Suisse.RxSight ( RXST ) said previously announced plans for former CFO Shelley Thunen to continue supporting the company in a consulting capacity remain in place. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

RXST

RxSight 已任命 Mark Wilterding 为新的首席财务官，任职时间从 2026 年 1 月 11 日开始。Wilterding 拥有超过 25 年的财务领导经验，曾担任 Edwards Lifesciences 的全球财务高级副总裁，并在 Medtronic、Citi 和瑞士信贷工作。公司确认，前首席财务官 Shelley Thunen 将继续以顾问身份支持 RxSight

RxSight 任命 Mark Wilterding 为首席财务官